The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 23, 2025 for Tenshi Pharmaceuticals ....
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tenshi Pharmaceuticals Private Limited, a promoter of Onesource Specialty Pharma, has filed a revised disclosure under SEBI Takeover Regulations regarding a pledge created on December 16, 2025. Tenshi Pharmaceuticals pledged 20,00,000 shares (about 1.75% of share capital) as security for a loan taken against shares, with Avendus PE Investment Trusteeship Limited acting as lender and Catalyst Advisors Private Limited as trustee. The original disclosure was filed on December 18, 2025, but the BSE raised a discrepancy on December 22, 2025 because the lender's name was left blank in the encumbrance details. The promoter has now corrected this clerical error and resubmitted the disclosure on December 23, 2025. No other promoter group's pledged holdings changed materially except for this addition.
Pledge creation by promoters is typically viewed as a mildly negative signal since it indicates borrowing against promoter holdings, but the size here is small (1.75%) and it is a routine loan-against-shares facility, so direct stock price impact should be limited. Investors should monitor if further pledges or any invocation/release events follow.